We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
More Favorable Short and Long-Term Outcomes for Screen-Detected Colorectal Cancer Patients.
- Authors
Spolverato, Gaya; Capelli, Giulia; Battagello, Jessica; Barina, Andrea; Nordio, Susi; Finotti, Elena; Mondi, Isabella; Da Lio, Corrado; Morpurgo, Emilio; Navarro, Josè Adolfo; Ceccato, Fabio; Perin, Alessandro; Pedrazzani, Corrado; Turri, Giulia; Zanus, Giacomo; Campi, Michela; Massani, Marco; Di Giacomo, Adriana; Prando, Daniela; Agresta, Ferdinando
- Abstract
Background: Screening significantly reduces mortality from colorectal cancer (CRC). Screen detected (SD) tumors associate with better prognosis, even at later stage, compared to non-screen detected (NSD) tumors. We aimed to evaluate the association between diagnostic modality (SD vs. NSD) and short- and long-term outcomes of patients undergoing surgery for CRC. Materials and Methods: This retrospective cohort study involved patients aged 50–69 years, residing in Veneto, Italy, who underwent curative-intent surgery for CRC between 2006 and 2018. The clinical multi-institutional dataset was linked with the screening dataset in order to define diagnostic modality (SD vs. NSD). Short- and long-term outcomes were compared between the two groups. Results: Of 1,360 patients included, 464 were SD (34.1%) and 896 NSD (65.9%). Patients with a SD CRC were more likely to have less comorbidities (p = 0.013), lower ASA score (p = 0.001), tumors located in the proximal colon (p = 0.0018) and earlier stage at diagnosis (p < 0.0001). NSD patients were found to have more aggressive disease at diagnosis, higher complication rate and higher readmission rate due to surgical complications (all p < 0.05). NSD patients had a significantly lower Disease Free Survival and Overall Survival (all p < 0.0001), even after adjusting by demographic, clinic-pathological, tumor, and treatment characteristics. Conclusions: SD tumors were associated with better long-term outcomes, even after multiple adjustments. Our results confirm the advantages for the target population to participate in the screening programs and comply with their therapeutic pathways.
- Subjects
VENETO (Italy); COLORECTAL cancer; PROGRESSION-free survival; CANCER patients; PROGNOSIS; DIAGNOSIS
- Publication
Frontiers in Oncology, 2021, Vol 11, pN.PAG
- ISSN
2234-943X
- Publication type
Article
- DOI
10.3389/fonc.2021.620644